Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study

In patients with stable coronary artery disease (CAD) without overt heart failure, ACE inhibitors are among the most commonly used drugs as these agents have been proven effective in reducing the risk of cardiovascular events. Considerable individual variations in the blood pressure response to ACE...

Descripción completa

Detalles Bibliográficos
Autores principales: Brugts, J. J., de Maat, M. P. M., Danser, A. H. J., Boersma, E., Simoons, M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247631/
https://www.ncbi.nlm.nih.gov/pubmed/21688035
http://dx.doi.org/10.1007/s12471-011-0173-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247631/
https://www.ncbi.nlm.nih.gov/pubmed/21688035
http://dx.doi.org/10.1007/s12471-011-0173-6

Ejemplares similares